European Commission President von der Leyen said on the 15th that people in EU countries may start vaccinated against the novel coronavirus as early as the end of this year.
According to a 24-hour French TV station on the 15th, von der Leyen tweeted that the European Drug Administration (EMA) decided to hold a special meeting on December 21 on the coronavirus vaccine jointly developed by Pfizer and BioNTech. The first Europeans may be vaccinated by the end of 2020.
If Pfizer/BioNTech’s coronavirus vaccine is licensed by the European Drug Administration, the European Commission will immediately consult with 27 EU member states, and the agreement can formally approve the vaccine to be put into use within three days.
The authority of the EMA is to issue recommendations for new drug treatments, while the European Commission has the final decision on drug approval, and the European Commission usually follows the EMA’s recommendations.
According to Reuters, German Health Minister Spahn said on the 15th that Germany will start vaccination within 24 hours to 72 hours after Pfizer/BioNTech’s vaccine is approved by the European Union, possibly starting at the earliest at Christmas.
The United States launched the first coronavirus vaccination outside clinical trials on December 14. On the first day of the COVID-19 vaccine was rolled out nationwide, Pfizer and its partners have delivered the first vaccine to 141 of the 145 locations designated by the U.S. government,
a spokesperson for the U.S. Department of Health and Human Services said. In addition, data released by the U.S. Food and Drug Administration (FDA) on the 15th showed that the coronavirus vaccine produced by Modena Company in the United States has a high protective effect on adults.
Sources said that the FDA may approve the emergency use authorization of Modena vaccine on the 18th.